Rein Therapeutics
(NASDAQ) RNTX
Rein Therapeutics Financials at a Glance
Market Cap
$41.78M
Revenue (TTM)
$0.00
Net Income (TTM)
$49.87M
EPS (TTM)
$-1.96
P/E Ratio
-0.76
Dividend
$0.00
Beta (Volatility)
1.00 (Low)
Dividend
$0.00
Beta (Volatility)
1.00 (Low)
Price
$1.49
Volume
40,402.007
Open
$1.53
Price
$1.49
Volume
40,402.007
Open
$1.53
Previous Close
$1.49
Daily Range
$1.42 - $1.58
52-Week Range
$1.02 - $2.40
Dividend
$0.00
Beta (Volatility)
1.00 (Low)
Price
$1.49
Volume
40,402.007
Open
$1.53
Previous Close
$1.49
Daily Range
$1.42 - $1.58
52-Week Range
$1.02 - $2.40
RNTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Rein Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
10
CEO
Brian J. Windsor, PhD
Website
www.reintx.comHeadquarters
Austin, TX 78758, US
RNTX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-140%
Return on Capital
-1%
Return on Assets
-2%
Earnings Yield
-1.32%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$41.78M
Shares Outstanding
28.04M
Volume
40.40K
Short Interest
0.00%
Avg. Volume
114.90K
Financials (TTM)
Gross Profit
$1.00K
Operating Income
$21.93M
EBITDA
$21.93M
Operating Cash Flow
$19.36M
Capital Expenditure
$0.00
Free Cash Flow
$19.36M
Cash & ST Invst.
$3.21M
Total Debt
$0.00
Rein Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$41.78M
N/A
Market Cap/Employee
$3.80M
N/A
Employees
11
N/A
Net Income
$31.97M
+22.0%
EBITDA
$3.87M
+90.9%
Quarterly Fundamentals
Net Cash
$3.21M
-75.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-2.06%
N/A
Return on Invested Capital
-1.22%
N/A
Free Cash Flow
$3.22M
+33.1%
Operating Cash Flow
$3.22M
+33.1%